Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127677941 | 12767794 | 1 | I | 20160913 | 20160921 | 20160921 | EXP | AU-MYLANLABS-2016M1040230 | MYLAN | NGUYEN TA, CAUGHEY G, PRATT N, SHAKIB S, KEMP A, ROUGHEAD E. HOSPITALIZATION FOR DRUG-INDUCED HEPATOTOXICITY: LINKING Y-CODES WITH PHARMACEUTICAL CLAIMS DATA TO IDENTIFY IMPLICATED MEDICINES. J-CLIN-PHARM-THER 2015;40(2):213-219. | 0.00 | Y | 0.00000 | 20160921 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127677941 | 12767794 | 1 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | U | 0 | |||||||||
| 127677941 | 12767794 | 2 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | U | 0 | |||||||||
| 127677941 | 12767794 | 3 | SS | MELOXICAM. | MELOXICAM | 1 | Unknown | D | 0 | ||||||||||
| 127677941 | 12767794 | 4 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | D | 0 | ||||||||||
| 127677941 | 12767794 | 5 | SS | CODEINE PHOSPHATE/PARACETAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | D | 0 | ||||||||||
| 127677941 | 12767794 | 6 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | U | 75973 | |||||||||
| 127677941 | 12767794 | 7 | SS | METOPROLOL. | METOPROLOL | 1 | Unknown | U | U | 0 | |||||||||
| 127677941 | 12767794 | 8 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127677941 | 12767794 | 1 | Hyperlipidaemia |
| 127677941 | 12767794 | 2 | Arteriosclerosis |
| 127677941 | 12767794 | 3 | Product used for unknown indication |
| 127677941 | 12767794 | 4 | Product used for unknown indication |
| 127677941 | 12767794 | 5 | Product used for unknown indication |
| 127677941 | 12767794 | 6 | Product used for unknown indication |
| 127677941 | 12767794 | 7 | Product used for unknown indication |
| 127677941 | 12767794 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127677941 | 12767794 | OT |
| 127677941 | 12767794 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127677941 | 12767794 | Hepatotoxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |